Drug Trial Radar · NCT06045299
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Last checked: Nov 20, 2026Latest source record: Mar 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Sep 27, 2023
Primary completion
Aug 19, 2024
Study completion Jan 27, 2025
Sponsor
- Lead sponsor
- Corxel PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- LENZ Therapeutics, Inc
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 45 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Phase 3 Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Treatment of Presbyopia
Conditions
- Presbyopia
- Near Vision
- Miosis
- Eye Diseases
Interventions
Aceclidine+Brimonidine combination ophthalmic solutionDrug
Aceclidine+Brimonidine combination ophthalmic solution
Aceclidine ophthalmic solutionDrug
Aceclidine ophthalmic solution
Placebo (Vehicle) ophthalmic solutionDrug
Placebo (Vehicle) ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best-corrected distance visual acuity (BCDVA) at 40 cmTime frame: 3 hours post-treatment in the study eye at Visit 2 (Day 1)
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tongren Hospital, Capital Medical University
Beijing, China
Peking University First Hospital
Beijing, China
The Second Xiangya Hospital of Central South University
Changsha, China
Ineye Hospital of Chengdu University of TCM
Chengdu, China
Dalian N0.3 people's hospital
Dalian, China
Guang Zhou Aier eye Hospital
Guangzhou, China
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, China
The Affiliated Hospital of Guizhou Medical University
Guiyang, China
Affiliated Eye Hospital, Shandong University of Traditional Chinese Medicine
Jinan, China
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, China
Tongji Hospital Of Tongji University
Shanghai, China
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School Of Medicine
Shanghai, China
Shanxi Eye Hospital
Taiyuan, China
Tianjin Eye Hospital
Tianjin, China
Tianjin Medical University Eye Hospital
Tianjin, China
Wuhan Aier Eye Hospital
Wuhan, China
Xi'An People's Hospital
Xi'an, China
Henan Eye Hospital & Henan Institute
Zhengzhou, China
Eye Hospital, Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.